The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 12802764.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We compared the mortality rate among patients suspected of having Crimean-Congo hemorrhagic fever (CCHF) who received treatment with oral ribavirin and those who did not. Ninety-seven (69.8%) of 139 treated patients suspected of having CCHF survived, and 61 (88.9%) of 69 treated patients with confirmed CCHF survived. The efficacy of oral ribavirin was 80% among patients with confirmed CCHF and 34% among patients suspected of having CCHF. Considering the limitations of observational studies, we conclude that oral ribavirin is an effective treatment for the hemorrhagic form of CCHF.
Medical subject headings
- Antiviral Agents
- Hemorrhagic Fever, Crimean
- Ribavirin